drugset / Trial / NCT07320521

A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.

NCT07320521

Phase 1 Completed 6 enrolled Shandong Suncadia Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This single-part, healthy volunteer study will try to identify how the test medicine is taken up, broken down and removed from the body. To help investigate this, the test medicine is radiolabelled, which means that the test medicine has a radioactive component (carbon-14) which helps us to track where the test medicine is in the body. The safety and tolerability of the test medicine will also be studied.

Timeline

Start
2026-01-09
Primary completion
2026-01-28
Completion
2026-01-28

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-8080 Unknown Oral

Indications